Advertisement Pharmaceutical Business review - Page 64 of 5269 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 20, 2026

MSD secures EC approval for Enflonsia to prevent infant RSV infection

Merck & Co (MSD) has received the European Commission (EC) approval for Enflonsia (clesrovimab), indicated to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their initial RSV season.

Continue
Enflonsia is indicated to prevent RSV lower respiratory tract disease in newborns and infants. Credit: Inara Prusakova / Shutterstock.com.
April 20, 2026

UCB to purchase Neurona and NRTX-1001 for $1.15bn

Neurona Therapeutics develops regenerative cell therapies for epilepsy and other nervous system conditions. Credit: UnderhilStudio / Shutterstock.com.
April 17, 2026

Aligos and Xiamen Amoytop sign deal for HBV therapy

Pevifoscorvir sodium is a potential first-in-class capsid assembly modulator being developed to treat chronic HBV. Credit: Jarun Ontakrai / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions
  2. Nucleai and Sirona Dx to provide new proteomics solution for pharma companies
  3. Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study
  4. Adcendo secures $75m in Series C funding for ADC development
  5. Lilly to acquire CrossBridge Bio for up to $300m

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography